Skip to Content

PGIM Jennison Health Sciences A PHLAX

Analyst rating as of
NAV / 1-Day Return
48.83  /  1.94 %
Total Assets
2.2 Bil
Adj. Expense Ratio
1.140%
Expense Ratio
1.140%
Fee Level
Low
Longest Manager Tenure
21.88 years
Category
Health
Investment Style
Mid Growth
Min. Initial Investment
1,000
Status
Open
TTM Yield
0.00%
Turnover
45%
Premium

Morningstar’s Analysis

Will PHLAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

PGIM Jennison Health Sciences Adds a Comanager; Ratings Unchanged

Analyst Note

| |

On Dec. 15, 2020, PGIM Investments added a member to the management roster of PGIM Jennison Health Sciences. The move doesn't alter the strategy's Above Average People rating or its Morningstar Analyst Rating of Silver for the cheaper shares and Bronze for the more expensive shares.

Unlock our full analysis with Morningstar Premium